Equities

DarioHealth Corp

DRIO:NAQ

DarioHealth Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.8203
  • Today's Change-0.010 / -1.16%
  • Shares traded5.86k
  • 1 Year change-17.97%
  • Beta1.5110
Data delayed at least 15 minutes, as of Nov 22 2024 15:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments375036
Total Receivables, Net5.186.901.71
Total Inventory5.067.966.23
Prepaid expenses--0.911.59
Other current assets, total--0.240.08
Total current assets476646
Property, plant & equipment, net1.871.990.99
Goodwill, net424242
Intangibles, net5.409.9212
Long term investments------
Note receivable - long term------
Other long term assets0.150.120.08
Total assets96119101
LIABILITIES
Accounts payable1.132.325.11
Accrued expenses6.416.898.07
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.958.82--
Other current liabilities, total1.001.321.20
Total current liabilities121914
Total long term debt25180
Total debt29270
Deferred income tax------
Minority interest------
Other liabilities, total1.161.740.85
Total liabilities383915
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital408366308
Retained earnings (accumulated deficit)(349)(286)(222)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity588086
Total liabilities & shareholders' equity96119101
Total common shares outstanding272617
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.